Intelligence Β· Clinical Pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
- Programs
- 4,713
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
-
OPB-51602
Hospital Authority, Hong Kong
Nasopharyngeal Carcinoma
1 trial -
OPC-108459
Otsuka Beijing Research Institute
Atrial Fibrillation
1 trial -
OPC1
Lineage Cell Therapeutics
Spinal Cord Injury Cervical
1 trial -
OPRX-106
Protalix BioTherapeutics
Human Volunteer
1 trial -
ORG-129
Agomab Therapeutics NV
Healthy Volunteers
1 trial -
ORIC-101
Topiloric/Uriadec
Prostatic Neoplasms
1 trial -
ORIC-101
Topiloric/Uriadec
Solid Tumor
1 trial -
ORIC-101
Topiloric/Uriadec
Healthy Volunteers
2 trials -
ORIC-114
Topiloric/Uriadec
Food Effect in Healthy Participants
1 trial -
ORIC-114 Dose 1 + amivantamab
Topiloric/Uriadec
Solid Tumors
1 trial -
ORIC-533
Topiloric/Uriadec
Relapsed or Refractory Multiple Myeloma
1 trial -
ORIC-944
Topiloric/Uriadec
Metastatic Prostate Cancer
1 trial -
ORKA-001
Oruka Therapeutics
Healthy Volunteers
1 trial -
ORKA-002
Oruka Therapeutics
Healthy Volunteers
1 trial -
OROS-MPH
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
1 trial -
ORX142 Tablets
Centessa Pharmaceuticals plc
Excessive Daytime Sleepiness
1 trial -
ORX489 Tablets
Centessa Pharmaceuticals plc
Healthy Adult Male and Female Volunteers
1 trial -
Obatoclax mesylate (GX15-070MS)
Teva Pharma GmbH
Hematological Malignancies
1 trial -
Obecabtagene autoleucel (obe-cel)
Autolus GmbH
Progressive Multiple Sclerosis
1 trial -
Obecabtagene autoleucel (obe-cel)
Autolus GmbH
Systemic Lupus Erythematosus
1 trial -
Octreotide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Enterocutaneous Fistulas
1 trial -
Odronextamab
Regeneron UK Limited
B-cell Non-Hodgkins Lymphoma (B-NHL)
1 trial -
Odronextamab multiple dose levels
Regeneron UK Limited
Non-Hodgkin Lymphoma
1 trial -
Olanzapine
CORCEPT THERAPEUTICS INC
Antipsychotic-induced Weight Gain
1 trial -
Olanzapine Extended Release
Teva Pharma GmbH
Schizophrenia, Schizoaffective Disorder
1 trial -
Olaparib tablets, 150 mg
Sandoz Pty Ltd
Ovarian Cancer
1 trial -
Olaratumab
Eli Lilly and Company
Malignancy
1 trial -
Olezarsen
IONIS PHARMACEUTICALS INC
Healthy Participants
1 trial -
Olfactory ensheathing cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Infarction, Middle Cerebral Artery
1 trial -
Olinciguat
Cyclerion Therapeutics
Healthy
1 trial -
Ologen Collagen Matrix
AEON Biopharma
Congenital Glaucoma
1 trial -
Olomorasib
Eli Lilly and Company
Healthy
1 trial -
Olutasidenib Investigational Agent Administration
RIGEL PHARMACEUTICALS INC
Acute Myeloid Leukemia
1 trial -
Olverembatinib, APG-2575, Dexamethasone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lymphoblastic Leukemia, Acute, Childhood
1 trial -
Omacetaxine
Teva Pharma GmbH
Hematologic Tumors
1 trial -
Omega 3 fatty acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Male Infertility Due to Hypospermatogenesis
1 trial -
Omega-3 fatty acids
NORTHWEST BIOTHERAPEUTICS INC
Metabolic Syndrome X
1 trial -
Omeprazole 40 MG
LEXICON PHARMACEUTICALS, INC.
Drug-drug Interaction
1 trial -
Omnitram
BRIGHT MINDS BIOSCIENCES INC.
Pain
1 trial -
Onartuzumab
Hoffmann-La Roche
Carcinoma, Hepatocellular
1 trial -
Oncolytic Virus SDJ001
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Malignant Tumor
1 trial -
Ondansetron
Teva Pharma GmbH
Healthy
2 trials -
Ondansetron
HALOZYME THERAPEUTICS, INC.
Healthy
1 trial -
Ondansetron (ODFS)
Aquestive Therapeutics
Healthy
1 trial -
Ondansetron 8 mg ODFS without water
Aquestive Therapeutics
Healthy Participants
1 trial -
One dose of investigational vaccine
Sinovac Research and Development Co.,
Hepatitis B
1 trial -
Ontamalimab
Takeda
Steatohepatitis
1 trial -
Open label, Phase I study to assess and compare the pharmacokinetic parameters after multiple oral administration of stiripentol 1000 mg in renal impaired patients and matching controls with normal renal function
Biocodex
Patients with renal impairement
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources Β· All pipeline programs